Company Directory

Company Directory

Company Directory - ProPharma Group

Company Details - ProPharma Group

ProPharma Group Logo

ProPharma Group

Website

ProPharma Group specializes in delivering comprehensive current Good Manufacturing Practice (cGMP) audits and GMP consulting services, helping pharmaceutical manufacturers ensure compliance and quality in production processes.

CCI Score

CCI Score: ProPharma Group

-52.87

0.03%

Latest Event

Pharmaceutical Lobbying Influence in Healthcare Sector

The article highlights that healthcare and pharmaceutical companies spent a record amount on lobbying in 2021, including $356 million on federal lobbying. This level of expenditure signals a deliberate effort to influence policy in favor of industry interests, potentially undermining democratic processes. Given ProPharma Group's role in serving the pharmaceutical sector, its indirect association with these practices raises concerns regarding its complicity in supporting a political environment that favors authoritarian policies.

Take Action

So what can you do? It's time to make tough choices. Where will you cast your vote?

Shop Alternatives
SEE ALL
Use Your Voice
OTHER TOOLS
Investigate
Share the Score
SUPPORT CCI

QUISLING

ProPharma Group is currently rated as a Quisling.

-44 to -59 CCI Score
These companies are fully aligned with authoritarian regimes. They not only support but also enforce oppressive policies, playing a significant role in the regime’s operational apparatus and contributing directly to its consolidation of power.

Latest Events

  • Pharmaceutical Lobbying Influence in Healthcare Sector Logo
    JUN
    29
    2022

    The article highlights that healthcare and pharmaceutical companies spent a record amount on lobbying in 2021, including $356 million on federal lobbying. This level of expenditure signals a deliberate effort to influence policy in favor of industry interests, potentially undermining democratic processes. Given ProPharma Group's role in serving the pharmaceutical sector, its indirect association with these practices raises concerns regarding its complicity in supporting a political environment that favors authoritarian policies.

  • -70

    Political Contributions and Lobbying Efforts

    March 18

    The article documents extensive lobbying efforts within the pharmaceutical industry, with spending reaching $356 million on federal lobbying in 2021. Lobbying on this scale is seen as an attempt to manipulate regulatory frameworks and secure advantages that align with authoritarian policies, thereby compromising democratic accountability. As a company serving the pharmaceutical sector, ProPharma Group is indirectly associated with these systemic issues, warranting a negative rating in the Political Contributions and Lobbying Efforts category.

    Healthcare Companies Spent More on Lobbying Than Any Other Industry Last Year

Industries

541519
Other Computer Related Services
541611
Administrative Management and General Management Consulting Services
541712
Research and Development in the Physical, Engineering, and Life Sciences (Biotechnology)